Clinical Trials Logo
  1. Home
  2. Embryo Transfer
  3. NCT01669083

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing

Embryo Transfer Clinical Trial

Official title:
A Phase I Non-Randomized Multi Cohort, Open Label, Bridging Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing

Clinical Trial Summary

GSK557296 is being studied in women for the indication of enhanced embryo and or blastocyst implantation in women undergoing IVF treatment. This study will be the first dosing experience with this compound in women. It is important to characterize the pharmacokinetics of GSK557296 in women to determine the most appropriate doses and dosing regimens for future clinical studies. Understanding the pharmacokinetics of GSK557296 in women will also enable more accurate characterization of any exposure-response relationship in future studies.

Two previous studies with GSK557296 were conducted in men with oral doses ranging from 10 milligram (mg) to 200 mg. GSK557296 is being studied in women for the indication of enhanced embryo and or blastocyst implantation in women undergoing IVF treatment. This is a bridging study to characterize the pharmacokinetics of GSK557296 in women to determine the most appropriate doses and dosing regimens for future clinical studies.

This is a non-randomized, open label, adaptive design study in healthy female volunteers. A maximum total of 48 subjects, will participate in different cohorts. Subjects in Cohort 1 will receive 10 mg single dose followed by repeat dose. A one week break will occur to allow for analysis of the PK data, prior to starting the second Cohort. Subjects in Cohort 2 will receive 150 mg single dose followed by repeat dose. Cohort 3 and Cohort 4 were adaptive based on the requirement of additional doses to be studies after PK data will be analyzed from each of the first 2 cohorts.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01669083
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date August 16, 2012
Completion date March 9, 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03642665 - Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer Phase 4
Completed NCT01919502 - Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment N/A
Completed NCT03292770 - Mucus Removal Before Embryo Transfer N/A
Recruiting NCT06134609 - Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer? N/A
Completed NCT03040830 - Effect of Timing Progesterone Luteal Support on Embryo Transfer Phase 4
Recruiting NCT04725864 - Progesterone as Luteal Support in Frozen IVF Natural Cycles Phase 4
Recruiting NCT04619524 - Biomarkers of Endometrial Receptivity N/A
Completed NCT04297553 - Fresh Versus Freeze-only After CAPA IVM on PCOS Patients N/A
Completed NCT01846403 - Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting N/A
Completed NCT02703181 - Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers Phase 1
Recruiting NCT02825290 - Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study Phase 4
Completed NCT01863680 - Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Phase 3
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT05364528 - Pregnancy Rate in Direct Versus Afterload Technique of Embryo Transfer
Completed NCT04253470 - Debate on Progesterone Elevation on the Day of Triggering
Completed NCT03581422 - Natural Cycles With Spontaneous Versus Induced Ovulation in FET
Completed NCT02257359 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers Phase 1
Not yet recruiting NCT06084793 - Music for Anxiety in Embryo Transfers N/A
Completed NCT03201783 - Immediate Versus Delayed FET Following a Stimulated IVF Cycle N/A